Martin Eichner

5.6k total citations · 1 hit paper
124 papers, 3.8k citations indexed

About

Martin Eichner is a scholar working on Epidemiology, Infectious Diseases and Modeling and Simulation. According to data from OpenAlex, Martin Eichner has authored 124 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Epidemiology, 28 papers in Infectious Diseases and 27 papers in Modeling and Simulation. Recurrent topics in Martin Eichner's work include COVID-19 epidemiological studies (26 papers), Influenza Virus Research Studies (22 papers) and Viral Infections and Outbreaks Research (13 papers). Martin Eichner is often cited by papers focused on COVID-19 epidemiological studies (26 papers), Influenza Virus Research Studies (22 papers) and Viral Infections and Outbreaks Research (13 papers). Martin Eichner collaborates with scholars based in Germany, United States and Belgium. Martin Eichner's co-authors include Klaus Dietz, Hans-Peter Duerr, Markus Schwehm, Martin Röcken, Bernd J. Pichler, Manfred Kneilling, William E. Collins, L. Molineaux, Hans H. Diebner and Geoffrey M. Jeffery and has published in prestigious journals such as Nature Medicine, Journal of Neuroscience and Blood.

In The Last Decade

Martin Eichner

122 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Simultaneous PET-MRI: a new approach for functional and morphological imaging

2008 729 citations Manfred Kneilling, Martin Eichner et al. profile →

Peers

Countries citing papers authored by Martin Eichner

Since Specialization

Citations

This map shows the geographic impact of Martin Eichner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Eichner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Eichner more than expected).

Fields of papers citing papers by Martin Eichner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Eichner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Eichner. The network helps show where Martin Eichner may publish in the future.

Co-authorship network of co-authors of Martin Eichner

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Eichner. A scholar is included among the top collaborators of Martin Eichner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Eichner. Martin Eichner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cost-utility analysis of increasing uptake of universal seasonal quadrivalent influenza vaccine (QIV) in children aged 6 months and older in Germany 2022 ·Human Vaccines & Immunotherapeutics ·(unknown), (unknown), B Poulsen Nautrup, Ruprecht Schmidt‐Ott, Martin Eichner, Markus Schwehm, Gaël Dos Santos, B. Ultsch, Rafik Bekkat-Berkani, Alfred von Krempelhuber, Ilse Van Vlaenderen, (unknown)	5
2	COVID-19 case findings and contact tracing in South German nursing homes 2022 ·BMC Infectious Diseases ·(unknown), (unknown), (unknown), Hannes Fischer, (unknown), (unknown), (unknown), (unknown), Martin Eichner	3
3	Three‐dimensional histology vs. serial section histology in the treatment of primary basal cell carcinoma: a randomized, prospective, blinded study of 569 tumours 2021 ·Journal of the European Academy of Dermatology and Venereology ·Lukas Kofler, Helmut Breuninger, (unknown), Martin Eichner, Hans‐Martin Häfner, Saskia Maria Schnabl	15
4	Oral Health Benefits in Medicare and Medicaid 2021 ·Journal of Oral and Maxillofacial Surgery ·B.D. Tiner, (unknown), Paul J. Schwartz, Robert S. Clark, (unknown), David Shafer, Martin Eichner, (unknown), (unknown), (unknown), Mark A. Egbert, (unknown), (unknown)	2
5	Cost-Utility of Quadrivalent Versus Trivalent Influenza Vaccine in Germany, Using an Individual-Based Dynamic Transmission Model 2016 ·PharmacoEconomics ·F Christiaan K Dolk, Martin Eichner, R Welte, (unknown), (unknown), B Poulsen Nautrup, Ilse Van Vlaenderen, Ruprecht Schmidt‐Ott, Markus Schwehm, Maarten J. Postma	36
6	ÖGD-Initiative zur Verbesserung der Durchimpfung bei Asylsuchenden 2016 ·Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz ·Stefan Brockmann, (unknown), (unknown), (unknown), Mirjam Schmid, (unknown), Martin Eichner	8
7	Assessment of Public Health and Economic Impact of Intranasal Live-Attenuated Influenza Vaccination of Children in France Using a Dynamic Transmission Model 2016 ·Applied Health Economics and Health Policy ·Laetitia Gerlier, Mark Lamotte, (unknown), Xavier Lenne, Fabrice Carrat, Catherine Weil-Olivier, Oliver Damm, Markus Schwehm, Martin Eichner	10
8	Public Health and Economic Impact of Vaccinating Children with a Quadrivalent live Attenuated Influenza Vaccine in France Using a Dynamic Transmission Model 2014 ·Value in Health ·Laetitia Gerlier, Catherine Weil-Olivier, Fabrice Carrat, Xavier Lenne, Mark Lamotte, (unknown), Martin Eichner	2
9	Public health impact and cost-effectiveness of intranasal live attenuated influenza vaccination of children in Germany 2014 ·The European Journal of Health Economics ·Oliver Damm, Martin Eichner, Markus A. Rose, Markus Knuf, Peter Wutzler, Johannes G. Liese, H. Krüger, Wolfgang Greiner	29
10	Finding and removing highly connected individuals using suboptimal vaccines 2012 ·BMC Infectious Diseases ·Beatriz Vidondo, Markus Schwehm, (unknown), Martin Eichner	13
11	Influence of Gestational Age, Cesarean Section and Hematocrit on IL-8 Concentrations in Plasma and Detergent-Lysed Whole Blood of Noninfected Newborns 2011 ·Transfusion Medicine and Hemotherapy ·Felix Neunhoeffer, (unknown), Martin Eichner, Christian F. Poets, Annette Wacker, Thorsten Orlikowsky	1
12	Long-TermIn VivoImaging of β-Amyloid Plaque Appearance and Growth in a Mouse Model of Cerebral β-Amyloidosis 2011 ·Journal of Neuroscience ·Jasmin K. Hefendehl, Bettina M. Wegenast‐Braun, Christian Liebig, (unknown), David V. Milford, Michael E. Calhoun, Shinichi Kohsaka, Martin Eichner, Mathias Jucker	111
13	Para‐phenylenediamine‐specific lymphocyte activation test: a sensitive in vitro assay to detect para‐phenylenediamine sensitization in patients with severe allergic reactions 2010 ·Experimental Dermatology ·Manfred Kneilling, Ulrich M. Caroli, Cornelia Grimmel, Jörg Fischer, Martin Eichner, Thomas Wieder, (unknown), Martin Röcken, Tilo Biedermann	16
14	Small islands and pandemic influenza: Potential benefits and limitations of travel volume reduction as a border control measure 2009 ·BMC Infectious Diseases ·Martin Eichner, Markus Schwehm, Nick Wilson, Michael G. Baker	33
15	Impact of public health interventions in controlling the spread of SARS: Modelling of intervention scenarios 2008 ·International Journal of Hygiene and Environmental Health ·Ralf Krumkamp, Hans-Peter Duerr, Ralf Reintjes, Amena Ahmad, (unknown), Martin Eichner	15
16	Influenza pandemic intervention planning using InfluSim: pharmaceutical and non- pharmaceutical interventions 2007 ·BMC Infectious Diseases ·Hans-Peter Duerr, Stefan Brockmann, Isolde Piechotowski, Markus Schwehm, Martin Eichner	37
17	Diagnostic value of nodule palpation in onchocerciasis 2007 ·Transactions of the Royal Society of Tropical Medicine and Hygiene ·Hans-Peter Duerr, Günter Raddatz, Martin Eichner	22
18	Infectiousness of smallpox relative to disease age: estimates based on transmission network and incubation period 2006 ·Epidemiology and Infection ·Hiroshi Nishiura, Martin Eichner	36
19	Analysis of Historical Data Suggests Long-lasting Protective Effects of Smallpox Vaccination 2003 ·American Journal of Epidemiology ·Martin Eichner	43
20	Development of Onchocerca volvulus microfilariae injected into Simulium species from Cameroon 1991 ·Medical and Veterinary Entomology ·Martin Eichner, Alfons Renz, G. Wahl, Peter Enyong	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact